Takaisin Tulosta

Autismikirjon häiriöt ja niiden samanaikaisuus ADHD:n kanssa

Lisätietoa aiheesta
Maria Sumia, Sami Leppämäki, Arja Voutilainen, Irma Moilanen ja Pekka Tani
16.12.2016

Kirjallisuutta

  1. Terveyden ja hyvinvoinnin laitos. Psykiatrian luokituskäsikirja. Suomalaisen tautiluokitus ICD-10:n psykiatriaan liittyvät diagnoosit. Luokitukset, termistöt ja tilasto-ohjeet 1/2012, toinen painos. Terveyden ja hyvinvoinnin laitos, 2012. «http://www.terveysportti.fi/terveysportti/icd10.koti»1
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth edition DSM-5. American Psychiatric Publishing, Washington DC, 2013
  3. Baird G, Simonoff E, Pickles A ym. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006;368:210-5 «PMID: 16844490»PubMed
  4. Kerola, K, Kujanpää S, Timonen, T. Autismin kirjo ja kuntoutus. Juva: PS-Kustannus 2009
  5. Sinzig J, Morsch D, Bruning N ym. Inhibition, flexibility, working memory and planning in autism spectrum disorders with and without comorbid ADHD-symptoms. Child Adolesc Psychiatry Ment Health 2008;2:4 «PMID: 18237439»PubMed
  6. Sinzig J, Bruning N, Morsch D ym. Attention profiles in autistic children with and without comorbid hyperactivity and attention problems. Acta Neuropsychiatr 2008;20:207-15 «PMID: 25385656»PubMed
  7. Rommelse NN, Franke B, Geurts HM ym. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010;19:281-95 «PMID: 20148275»PubMed
  8. Cross-Disorder Group of the Psychiatric Genomics Consortium.. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381:1371-9 «PMID: 23453885»PubMed
  9. Leyfer OT, Folstein SE, Bacalman S ym. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 2006;36:849-61 «PMID: 16845581»PubMed
  10. Mattila ML, Hurtig T, Haapsamo H ym. Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study. J Autism Dev Disord 2010;40:1080-93 «PMID: 20177765»PubMed
  11. Nijmeijer JS, Minderaa RB, Buitelaar JK ym. Attention-deficit/hyperactivity disorder and social dysfunctioning. Clin Psychol Rev 2008;28:692-708 «PMID: 18036711»PubMed
  12. Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders. J Autism Dev Disord 2013;43:2435-41 «PMID: 23468071»PubMed
  13. Ji N, Findling RL. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry 2015;28:91-101 «PMID: 25602248»PubMed
  14. Béhérec L, Quilici G, Rosier A ym. [Pharmacological treatments in patients with pervasive developmental disorders: A review]. Encephale 2014;40:188-96 «PMID: 24369879»PubMed
  15. Baribeau DA, Anagnostou E. An update on medication management of behavioral disorders in autism. Curr Psychiatry Rep 2014;16:437 «PMID: 24488702»PubMed
  16. Fisman S. Pervasive developmental disorder. Kirjassa: Kutcher S (toim.) Practical Child and Adolescent Psychopharmacology. Cambridge University Press, 2002
  17. Zeiner P, Gjevik E, Weidle B. Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder. Acta Paediatr 2011;100:1258-61 «PMID: 21392103»PubMed
  18. Charnsil C. Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study. J Atten Disord 2011;15:684-9 «PMID: 20686100»PubMed
  19. Levy SE, Mandell DS, Schultz RT. Autism. Lancet 2009;374:1627-38 «PMID: 19819542»PubMed